Sight Sciences, Inc. (SGHT)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 3.3700 |
| 開市 | 3.3800 |
| 買盤 | 3.0800 x 800 |
| 賣出價 | 3.4800 x 800 |
| 今日波幅 | 3.2650 - 3.4500 |
| 52 週波幅 | 2.7800 - 15.2950 |
| 成交量 | |
| 平均成交量 | 206,403 |
| 市值 | 163.954M |
| Beta 值 (5 年，每月) | 1.14 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.5300 |
| 業績公佈日 | 2023年8月03日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.63 |
BenzingaSight Sciences' Near-Term Upside Is Limited, Says This Analyst
Needham initiated coverage on Sight Sciences Inc (NASDAQ: SGHT) with a Hold rating and no price target. The analyst warns that the recent competitive launches in the minimally invasive glaucoma surgery (MIGS) market will be a headwind to Sight Sciences' revenue growth and limit the stock's near-term upside. SGHT's OMNI system, which generated 95% of 2021 sales, is used to treat glaucoma by targeting the drainage channels in the eye. Needham believes most OMNI procedures are for mild- to moderate
